Views: 130 Author: Site Editor Publish Time: 2023-04-18 Origin: Site
Strength: 0.2ml:2000IU 0.4ml:4000IU 0.6ml:6000IU 0.8ml:8000IU
Package: 2 prefilled syringe / box
Specification: USP
Method: Subcutaneous injection
Indication:
1. Prophylaxis of Deep Vein Thrombosis
2. Treatment of Acute Deep Vein Thrombosis
3. Prophylaxis of Ischemic Complications of Unstable Angina and Non–Q-Wave Myocardial Infarction
4. Treatment of Acute ST-Segment Elevation Myocardial Infarction
1. It applies to the widest range of people
Drug category | Indication | |||||
Prevent VTE | Treat DVT | |||||
Internal medicine | Surgery (non-Orthopaedic) | The orthopaedic trauma | Major orthopedic surgery | Without PE | With PE | |
Low Molecular Weight Heparin | ||||||
Enoxaparin | √ | √ | √ | √ | √ | √ |
Nadroparin | × | √ | √ | √ | √ | × |
Dalteparin | × | √ | √ | √ | √ | × |
Heparin | √ | √ | √ | √ | √ | √ |
Fondaparinux | × | × | × | √ | × | × |
Warfarin | √ | √ | √ | √ | √ | √ |
DOACs | ||||||
Dabigatran | Prevention of stroke and systemic embolism in patients with nVAF | × | × | |||
Rivaroxaban | × | × | × | √ | √ | √ |
2. The anticoagulant activity is the strongest and the effect is the fastest
Enoxaparin sodium is a kind of low molecular heparin, which is prepared by alkali depolymerization of heparin benzyl ester derivatives from porcine intestine mucosa as raw material, with faster onset time, longer clearance half-life and higher titer. It is the most widely used low molecular heparin with the most indications in the world.
3. Traceability control of Enoxaparin sodium API
Our quality control started from Casing workshop. Each batch of crude heparin is traceable. On-site collecting and processing of intestines are made by crude heparin workshops with systematic techniques. Records for details are well made and kept for traceability.
4. The most extensive clinical application and the most complete theoretical basis
Enoxaparin was first made in 1981 and approved for medical use in 1993 by Aventis(merged with Sanofi later) in the trade name of Lovenox in 1993.
It is on the World Health Organization's model List of Essential Medicines, medicines needed in a health system. It has been on the market worldwide for 30 years and served more than 700 million patients, becoming a hard- core anticoagulation product trusted by patients.
5. Unique advantages of Nuobai pharmaceutcial Co., LTD as supplier of Enoxaparin sodium inj
Nuobai, as a experienced and important player of enoxaparin sodium injection , has been cultivating in the market for many years and have unique advantages in supply such as market dynamic, vertical industrial chain, traceability control, quick response of complete dossier and GMP site inspection.
Nuobai pharmaceutcial Co., LTD
We have vertical industrial advantages and started with processing porcine mucosa, which means stable supply chain and good quality under control. All the batch of crude heparin is traceable. Nuobai never experienced rejection due to quality issues. Meanwhile nuobai is familiar with registration requirements of different countries and support GMP site inspection. Nuobai can supply complete CTD format dossier, which can comply with requirements of different markets.
Written by Shirly Ran
